The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple Myeloma: In Vitro and In Vivo Studies
Open accessAbstract
Of patients with newly diagnosed multiple myeloma, approximately 10% have dialysis-dependent acute renal failure, with cast nephropathy, caused by monoclonal free light chains (FLC). Of these, 80 to 90% require long-term renal replacement therapy. Early treatment by plasma exchange reduces serum FLC concentrations, but randomized, controlled trials have shown no evidence of renal recovery. This outcome can be explained by the low efficiency of the procedure. A model of FLC production, distribution, and metabolism in patients with myeloma indicated that plasma exchange might remove only 25% of the total amount during a 3-wk period. For increasing FLC removal, extended hemodialysis with a protein-leaking dialyzer was used. In vitro studies indicated that the Gambro HCO 1100 dialyzer was the most efficient of seven tested. Model calculations suggested that it might remove 90% of FLC during 3 wk. This dialyzer then was evaluated in eight patients with myeloma and renal failure. Serum FLC reduced by 35 to 70% within 2 hr, but reduction rates slowed as extravascular re-equilibration occurred. FLC concentrations rebounded on successive days unless chemotherapy was effective. Five additional patients with acute renal failure that was caused by cast nephropathy then were treated aggressively, and three became dialysis independent. A total of 1.7 kg of FLC was removed from one patient during 6 wk. Extended hemodialysis with the Gambro HCO 1100 dialyzer allowed continuous, safe removal of FLC in large amounts. Proof of clinical value now will require larger studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Kyle, R. A., Gertz, M. A., Witzig, T. E., Lust, J. A., Lacy, M. Q., Dispenzieri, A., Fonseca, R., Rajkumar, S. V., Offord, J. R., Larson, D. R., et al. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.1.21 · Cited by 2,447 · cited 7×
“Extended daily hemodialysis for cast nephropathy 9 Gambro HCO 1100 13 4.8 (2 to 8) 445 45 18.1 (1.6 to 56) 370 17.1 95c 10 Gambro HCO 1100 (1) 12 7.25 (1 to 10) 22,408 36 439 (15 to 1610) 9700 9.2 50 (2) 6 6.5 (6 to 8) 17,610 57 514 (187 to 1370) 15,700 25.6 (3) 1 8 18,800 75 515 (151 to 1810) 11,600 31.5 11 Gambro HC…”
MethodInfluentialHighly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine
Bradwell, A. R., Carr-Smith, H. D., Mead, G. P., Tang, L. X., Showell, P. J., Drayson, M. T., & Drew, R. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.673 · Cited by 650
Self-citationKatzmann, J. A., Clark, R. J., Abraham, R. S., Bryant, S. C., Lymp, J. F., Bradwell, A. R., & Kyle, R. A. (2002) · PubMed · Cited by 620
Self-citationBladé, J., Fernández-Llama, P., Bosch, F., Montolíu, J., Lens, X. M., Montoto, S., Cases, A., Darnell, A., Rozman, C., & Montserrat, E. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1889 · Cited by 383
Renal failure in multiple myeloma: reversibility and impact on the prognosis
Knudsen, L. M., Hjorth, M., Hippe, E., & Nordic Myeloma Study Group (2000) · European Journal of Haematology · doi:10.1034/j.1600-0609.2000.90221.x · Cited by 380
Plasma Exchange When Myeloma Presents as Acute Renal Failure: A Randomized, Controlled Trial
Clark, W. F., Stewart, A. K., Rock, G. A., Sternbach, M., Sutton, D. M., Barrett, B. J., Heidenheim, A. P., Garg, A. X., Churchill, D. N., & and the Canadian Apheresis Group (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-11-200512060-00005 · Cited by 332
Oakervee, H. E., Popat, R., Curry, N., Smith, P., Morris, C., Drake, M., Agrawal, S., Stec, J., Schenkein, D., Esseltine, D., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05519.x · Cited by 317
Serum free light chains for monitoring multiple myeloma
Mead, G. P., Carr‐Smith, H. D., Drayson, M. T., Morgan, G. J., Child, J. A., & Bradwell, A. R. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05045.x · Cited by 196
Self-citationRenal Pathologic Spectrum in an Autopsy Series of Patients With Plasma Cell Dyscrasia
Herrera, G. A., Joseph, L., Gu, X., Hough, A. J., & Barlogie, B. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-875-rpsiaa · Cited by 144
Torrá, R., Bladé, J., Cases, A., López-Pedret, J., Montserrat, E., Rozmán, C., & Revert, L. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05400.x · Cited by 134
Myeloma : biology and management
Malpas, J. S., Bergsagel, D. E., & Kyle, R. A. (1995) · Cited by 107
Human alpha 1-microglobulin levels in various body fluids.
Takagi, K., Kin, K., Itoh, Y., Enomoto, H., & Kawai, T. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.8.786 · Cited by 68
Light‐chain removal by plasmapheresis in myeloma‐associated renal failure
Cserti-Gazdewich, C. M., Haspel, R. L., Stowell, C. P., & Dzik, S. (2007) · Transfusion · doi:10.1111/j.1537-2995.2006.01143.x · Cited by 62
Epidemiology of Multiple Myeloma
Baris, D., Brown, L. M., Andreotti, G., & Devesa, S. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_28 · Cited by 29
Pratt, G., Mead, G. P., Godfrey, K. R., Hu, Y., Evans, N. D., Chappell, M. J., Lovell, R., & Bradwell, A. R. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500254216 · Cited by 29
Self-citationGertz, M. A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-11-200512060-00013 · Cited by 20
Cited by
Rhabdomyolysis and Acute Kidney Injury
Bosch, X., Poch, E., & Grau, J. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801327 · Cited by 1,488
Hutchison, C. A., Harding, S., Hewins, P., Mead, G. P., Townsend, J., Bradwell, A. R., & Cockwell, P. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02290508 · Cited by 364
Self-citationBiochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
Vanholder, R., Pletinck, A., Schepers, E., & Glorieux, G. (2018) · Toxins · doi:10.3390/toxins10010033 · Cited by 356
Pathogenesis and treatment of renal failure in multiple myeloma
Dimopoulos, M. A., Kastritis, E., Rosinol, L., Bladé, J., & Ludwig, H. (2008) · Leukemia · doi:10.1038/leu.2008.131 · Cited by 305
Hutchison, C. A., Bradwell, A. R., Cook, M., Basnayake, K., Basu, S., Harding, S., Hattersley, J., Evans, N. D., Chappel, M. J., Sampson, P., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04590908 · Cited by 253
Self-citation
Metadata
- Authors
- Hutchison, C. A., Cockwell, P., Reid, S., Chandler, K., Mead, G. P., Harrison, J., Hattersley, J., Evans, N. D., Chappell, M. J., Cook, M., Goehl, H., Storr, M., & Bradwell, A. R.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2007-03
- Volume
- 18
- Issue
- 3
- Pages
- 886-895
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2149024804
- Cited by
- 270
- References
- 16
- FWCI
- 11.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.